Teeraananchai Sirinya, Puthanakit Thanyawee, Kerr Stephen J, Chaivooth Suchada, Kiertiburanakul Sasisopin, Chokephaibulkit Kulkanya, Bhakeecheep Sorakij, Teeraratkul Achara, Law Matthew, Ruxrungtham Kiat
HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Kirby Institute, University of New South Wales, Sydney, Australia.
J Virus Erad. 2019 Jan 1;5(1):33-40. doi: 10.1016/S2055-6640(20)30276-4.
There are limited data describing the care outcome of youth living with HIV in Asia. We assessed attrition and treatment outcomes among youths with behaviourly acquired HIV (BIY) and adolescents with perinatally acquired HIV (PIY) who initiated antiretroviral treatment (ART) through the National AIDS Program (NAP) in Thailand.
People living with HIV aged 10-24 years who initiated antiretroviral therapy (ART) from 2008 to 2013 through the Thai NAP and who were followed up until 2014 were included in the analysis. We assessed youths initiating ART: BIY aged 15-19 years (BIY1) and BIY aged 20-24 (BIY2) compared against PIY aged 10-14 years. Attrition rates (mortality and loss to follow-up [LTFU]) were calculated and potential associations were assessed using Cox regression. Logistic regression was used to assess associations with treatment failure.
Of 11,954 individuals, 9909 (83%) were BIY with a median follow-up of 2.1 years and 17% were PIY with 4.2 years of follow-up. The median baseline CD4 cell count in BIY was higher (190 154 cells/mm) compared to PIY. Mortality rates were not significantly different among PIY (2.5 per 100 person years [PY], BIY1 3.1/100 PY and BIY2 2.9/100 PY, =0.46). Compared to PIY with a crude LTFU rate of 2.9/100 PY, LTFU was higher in BIY1 (13.9/100 PY) and BIY2 (9.5/100 PY), <0.001 and <0.001, respectively. At 1 year after initiating ART, 16% experienced virological failure (viral load above 1000 copies/mL). Combined treatment failure and LTFU rates at 1 year after ART were higher among BIY1 (45.0%) and BIY2 (34.4%) compared to PIY (29.9%), <0.001 and 0.001, respectively.
Youth with behaviourally acquired HIV aged 15-19 years had poorer retention rates than older BIY and PIY. Targeted interventions for youth are urgently needed to improve overall treatment outcomes.
关于亚洲感染艾滋病毒青少年的护理结果的数据有限。我们评估了通过泰国国家艾滋病项目(NAP)开始抗逆转录病毒治疗(ART)的行为感染艾滋病毒青年(BIY)和围产期感染艾滋病毒青少年(PIY)的失访情况和治疗结果。
分析纳入了2008年至2013年通过泰国NAP开始抗逆转录病毒治疗(ART)并随访至2014年的10至24岁艾滋病毒感染者。我们评估了开始接受ART的青年:15至19岁的BIY(BIY1)和20至24岁的BIY(BIY2),并与10至14岁的PIY进行比较。计算失访率(死亡率和失访[LTFU]),并使用Cox回归评估潜在关联。使用逻辑回归评估与治疗失败的关联。
在11954名个体中,9909名(83%)为BIY,中位随访时间为2.1年,17%为PIY,随访时间为4.2年。BIY的基线CD4细胞计数中位数(190±154个细胞/mm³)高于PIY。PIY的死亡率(每100人年2.5例[PY])与BIY1(3.1/100 PY)和BIY2(2.9/100 PY)之间无显著差异(P=0.46)。与PIY的粗LTFU率2.9/100 PY相比,BIY1(13.9/100 PY)和BIY2(9.5/100 PY)的LTFU率更高,P分别<0.001和<0.001。开始ART后1年,16%的人出现病毒学失败(病毒载量高于1000拷贝/mL)。与PIY(29.9%)相比,ART后1年BIY1(45.0%)和BIY2(34.4%)的联合治疗失败和LTFU率更高,P分别<0.001和0.001。
15至19岁行为感染艾滋病毒的青年的留存率低于年龄较大的BIY和PIY。迫切需要针对青年的有针对性干预措施,以改善总体治疗结果。